PROVIDER PROFILE · NPI 1760114755
Rachel Bruening
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
3,199
Beneficiaries
—
Total drug cost
$149K
Distinct drugs
76
Brand share
17.8%
Top prescribed drugs
Atorvastatin Calcium184 claims
Lisinopril171 claims
Omeprazole152 claims
Furosemide152 claims
Simvastatin139 claims
QUALITY · MIPS · 2024
Final MIPS score
85.5
Quality
81.0
Cost
70.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.44%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE